GREY:ATBPF - Post by User
Comment by
MasterAlgaeon Jun 30, 2021 12:59pm
143 Views
Post# 33473727
RE:Phase 3 Delay
RE:Phase 3 DelayThat Covid delay was expected, hence the long drift down since the $6.00 mark. Let's hope that the Delta variant fades away in USA, Europe and elsewhere - otherwise...
What the mkt wants to see is the vote of confidence in H2S, and that Antibe is not going to do Phase III alone. (MasterAlgae won't even go there). That vote of confidence comes from another partnership, North American or European.
After the partnership announcement then the NASDAQ is a formality and as the CEO has stated the paperwork is ready to go.
Forestview wrote: So, see below for what Dan said. Though things are opening up after Covid, there is likely a massive backlog...also, Nasdaq uplist is expected to be tied to a Phase 3 start, so eventhough it wasn't mentioned in the news release it's still happening. Last thing - a CEO update is coming in a couple of weeks...
We will experience a 6-8 week delay due to new Covid-related restrictions in Ontario imposed on Phase 1 clinics in May (we now have to do the study in 3 waves rather than 2). And the FDA itself is behind on it’s timings for meeting. Say another 4 weeks. Putting these together means that we think it’s unlikely we’d get our meeting before Christmas. Tiny stuff, but it’s a retail stock market. We are focused on the big prize: positive Phase III and at the same time, partnering (look at our China Nuance deal). Not sure what you mean by ‘momentum’ – we’re not a promotional agency.